jump to example.com

UVa. makes breakthrough in peripheral arterial disease

uva-logoA discovery at the University of Virginia School of Medicine is opening up new avenues for treating peripheral arterial disease (PAD), a common circulation problem that afflicts millions of Americans. Researchers have pinpointed a key genetic regulator that appears to controls the ability to adapt to blockages in blood vessels – and it turns out to be a tiny RNA molecule.

The finding gives researchers a new target for potential therapies to treat patients with peripheral arterial disease, as well as allowing them to better understand the progression of the disease in patients.

“Why does one person with peripheral arterial disease remain stable and do well while another person has a much worse clinical course? We need to begin to unravel these types of questions,” said Brian Annex, MD, division chief of cardiovascular medicine at UVA. “When we see a patient with peripheral arterial disease, the reality is that information we get out of their age, gender, risk factors and basic clinical measures doesn’t tell us how the patient is going to do. We’re often left with uncertainty. I think as we begin to understand the [implications of the discovery] we will better understand PAD and open up entirely new treatment approaches.”

The Causes of PAD
Peripheral arterial disease is caused by atherosclerosis that builds up inside the arteries and impedes blood flow, most often to the legs. Treatments to date have been ineffective at improving blood flow in PAD.

UVA’s discovery may help change that. The researchers determined that a specific “microRNA” molecule, microRNA-93, appears to control the expression of several related genes in mouse models of PAD.

“This microRNA had profound effects on both endothelial and muscle cells. Whether we used a gain of function or loss of function, in pretty much every situation, whenever we got a gain of function or a therapeutic benefit, the microRNA was present at a higher level and suppressed three genes,” Annex said. “Whenever you had less miR-93, you had more expression of these and a poorer response to injury/repair.”

Overturning Orthodoxy
Scientists once thought that microRNAs were effectively junk with no ability to generate proteins. But recently microRNAs have emerged as major regulators of how genes respond to injury. In the case of PAD, the UVA researchers found, microRNA-93 directs how genes react to the restriction in blood supply.

“The central dogma of molecular biology — that DNA makes RNA and RNA makes protein — is probably wrong more often than it’s right,” Annex said.

New Treatments for Peripheral Arterial Disease
UVA’s discovery presents an exciting new possibility of treating PAD by boosting the effects of microRNA-93, Annex said.

“To date, drugs used to treat patients with PAD have always tried to target a single gene, whereas it’s very clear this microRNA has significant effects on multiple related genes,” Annex said. “This opens up an entirely new paradigm for treating and understanding peripheral arterial disease.”

While more research needs to be done, Annex foresees several potential ways doctors could manipulate microRNA-93 to target PAD and avoid problems that plague other efforts to develop new treatments.

“One can imagine a direct strategy of delivering the microRNA, one can imagine a strategy to change the body’s own expression of the microRNA, one can try to figure out ways to prevent the breakdown of the microRNA,” he said. “Many of the strategies that are being set up to treat patients with peripheral arterial disease try to grow new blood vessels. Our microRNA will grow blood vessels, but what’s absolutely fascinating is that … it not only makes new blood vessels, but the blood vessels have structure and architecture and may very well get around the prior problems where drugs cause the development of leaky, malformed blood vessels.”

Published in 
Circulation
The new findings have been detailed in a paper published online by the journal Circulation. The article was authored by Surovi Hazarika, MD, PhD; Charles R. Farber, PhD; Ayotunde O. Dokun, MD, PhD; Achilleas N. Pitsillides, PhD; Tao Wang, MD, PhD; R. John Lye, PhD; and Annex.

Discussion
 
Top News
 
a

Study: UVA slashes opioid use while improving pain scores

A study of more than 100,000 surgical cases at UVA Health System found patients’ pain scores improved even as doctors gave fewer opioids.

Street Knowledge with Chris Graham: Wrapping #16 UVA road win

Chris Graham breaks down the 71-54 road win for #16 UVA at Boston College on this installment of Street Knowledge.

Fishburne Military School preps for the Inaugural Parade

Fishburne Military School preps for its appearance the 58th Inaugural Parade with a march through the streets of Waynesboro.

Virginia hospitals to lawmakers: 'Do no harm' on healthcare

The Virginia hospital community is advocating a do no harm approach to state legislation on healthcare policy.

Poll: Virginians want restraint on healthcare policy changes

New polling from Mason-Dixon Polling & Research shows strong majorities of Virginians are concerned about the future of healthcare.

Suicide intervention training offered in February

The American Foundation for Suicide Prevention will host the Applied Suicide Intervention Skills Training program Feb. 23-24.

Street Knowledge with Chris Graham: UVA hoops going all-in with four-guard lineup?

Street Knowledge with Chris Graham talks more UVA basketball, and examines the Cavs' upcoming week in the ACC.

Tom Perriello on Affordable Care Act: Where does Ed Gillespie stand?

Tom Perriello, famously, voted for the Affordable Care Act in his one term as Fifth District Congressman.

New Myers Corner website online: Produced by Augusta Free Press

The Myers Corner development in Augusta County has a new website designed by Augusta Free Press.

Anatomy of failed government: Another look at the DuPont settlement debacle

So much wailing and gnashing of teeth in Waynesboro over being shut out of the $50 million settlement with DuPont, and for what?

 
Recent News


Viewpoints


Hosts Chris Graham and Crystal Graham of Augusta Free Press highlight local news and newsmakers with an emphasis on the Shenandoah Valley on Viewpoints on WVPT.

Show airs Wednesday nights at 7:30 p.m.

Your One-Stop Media Shop

Augusta Free Press LLC provides clients in the Shenandoah Valley and Central Virginia and beyond with marketing and PR solutions including web design, magazine/brochure, TV/radio, social media and overall marketing campaign design and implementation.
  • Web Design

    You want a new website, but don’t have the first clue as to how to build one. That’s our job. We take care of all facets of web design – visual design, layout design and content development. Get your business online for as little as $1,299.
    Learn more about AFP Web Design services.
  • Graphic Design

    The staff at Augusta Free Press Publishing has been recognized by the Virginia Press Association for excellence in layout and design. Whether you need a fresh business card design, rack card, ad, flyer or full magazine design, we can help with all your graphic-design needs.
    Learn more about AFP Graphic Design services.
  • Marketing

    Augusta Free Press manages advertising campaigns for small- and medium-sized businesses across Virginia. You don’t need to hire a full-time marketing coordinator. Bring the experience of the Augusta Free Press team to work for you – for a fraction of the cost.
    Learn more about AFP Marketing services.